Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Atlas Capital Highlights Growing Gap Between Value Creation and Market Recognition in India’s Capital Markets Business
  • Are we heading towards cardiometabolic syndrome endemicity? Health
  • Right Paydays Launches for 2025: Compare Top Loan Offers in One Click Business
  • From SEO Specialist to Agency Founder: Ashwani Kumar Sharma’s Journey with eSign Web Services Lifestyle
  • Mahamaya Lifesciences Limited Announces Opening of Initial Public Offering (IPO) on November 11, 2025 Business
  • Parul University hosts Freshers Fest 2022, a carnival-like experience attended by over 11,000 new students Press Release
  • Binu Bhasuran Announces SAM Agent for Employee Support and WhatsApp Customer Support Business
  • Transforming Tomorrow: HestaBit’s Action Plan for AI, SAP, and VR Technology

A Pharmaceutical Injectable Manufacturing Company, opens its IPO on 21st May, 2026.

Posted on May 20, 2026 By

Mumbai (Maharashtra) [India], May 20: Bio Medica Laboratories Limited, engaged in the manufacturing of pharmaceutical parenteral formulations including liquid injectables and dry powder injectables for human and veterinary use, has announced the opening of its Initial Public Offering on May 21, 2026. The shares are proposed to be listed on the NSE Emerge Platform.

  • Fresh Issue Size – Up to 33,95,000 Equity Shares of ₹ 10 each
  • Offer for Sale Size – Up to 3,77,000 Equity Shares of ₹ 10 each
  • Total Issue Size – Up to 37,72,000 Equity Shares of ₹ 10 each
  • Issue Size – ₹ 52.43 Crore
  • Issue Price – ₹ 132 – ₹ 139 Per Share
  • Lot Size – 1,000 Equity Shares

Equity Share Allocation

  • QIB – Not more than 36,000 Equity Shares
  • NII – Not less than 17,55,000 Equity Shares
  • RII – Not less than 17,92,000 Equity Shares
  • Market Maker – 1,89,000 Equity Shares

The net proceeds from the IPO will be utilized towards repayment of loans, enhancement of existing production capabilities by setting up a new manufacturing facility at the existing premises, and general corporate purposes.

The issue will open for public subscription on Thursday, May 21, 2026 and close on Monday, May 25, 2026.

Narnolia Financial Services Limited is acting as the Book Running Lead Manager to the issue, and Skyline Financial Services Private Limited is the Registrar to the issue.

Mr. Pradeep Mehta, Managing Director, Bio Medica Laboratories Limited said: “The launch of our IPO marks a significant milestone in the journey of Bio Medica Laboratories Limited. Since our inception, we have remained committed to manufacturing high-quality pharmaceutical injectable formulations while maintaining stringent quality standards and regulatory compliance.

Over the years, we have built strong capabilities in liquid and dry powder injectables, supported by GMP & GLP certified manufacturing facilities and advanced quality control infrastructure. Our contract manufacturing model has enabled us to establish long-term relationships with customers across multiple states and therapeutic categories.

The proceeds from the IPO will support the expansion and upgradation of our manufacturing facilities, enhance our production capabilities, and strengthen our operational efficiency. With increasing demand in the injectable pharmaceutical market, we believe we are well positioned to scale our business and create long-term value for all our stakeholders.”

About The Company:

Bio Medica Laboratories Limited is engaged in manufacturing pharmaceutical parenteral formulations including liquid injectables and dry powder injectables for both human and veterinary use. The Company operates on a B2B contract manufacturing model and formulates products as per client requirements.

The Company currently manufactures 58 liquid injectables and 15 dry powder injectables across its two manufacturing units located in Indore, Madhya Pradesh. Its facilities are GMP & GLP certified by the Food & Drugs Administration, Madhya Pradesh.

The Company has an in-house quality control laboratory equipped with advanced instruments such as HPLC, GC, UV-Vis, and polarimeter to ensure efficient and accurate testing. The Company caters to customers across 15 states and serves both domestic and export markets.

In FY25, the Company recorded Revenue from Operations of ₹3,819.52 Lakhs, EBITDA of ₹1,521.33 Lakhs, and PAT of ₹979.49 Lakhs.

For Nov’25, the Company reported Revenue from Operations of ₹2,854.69 Lakhs, EBITDA of ₹1,344.72 Lakhs, and PAT of ₹866.39 Lakhs.

Disclaimer:

Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances.

If you object to the content of this press release, please notify us at pr.error.rectification@gmail.com. We will respond and rectify the situation within 24 hours.

Business Tags:Business

Post navigation

Previous Post: The Next Economy Forum 2026 Returns to the House of Lords, UK Parliament
Next Post: PSS Legal Appoints Rakhi Kapoor As its Chief Wellness Officer, Marking A First For India’s Corporate Legal Sector

Related Posts

  • Kanjurmarg gears up to be a commercial hub with two upcoming Metro Lines & arterial roads Business
  • TellMe DigiInfotech Receives The Prestigious Best Travel Tech Company Award At ET Travel & Tech Conclave, Gurgaon Business
  • Delhi to Host WebFair 25th Edition, Bringing Together India’s Growing Digital Business Community Business
  • Ceratec Group Launches Presidential Towers in Ravet, Pune Business
  • The Indian Alert Presents International Visionaries Summit & Awards 2025 – Dubai Edition Celebrates Global Leaders of Change Business
  • Zocket Earns Great Place to Work Certification—Because Thriving Teams Build Thriving Companies Business

Recent Posts

  • Delhi Witnesses Young Aavya M Bhutoria’s Kathak Debut at Aarohan 2026
  • Birth Centenary Celebrations to Convey the Message of Nation-Building Through Coordination Between Religious and Political Institutions
  • IBMA Organises First-Ever Indian Lead Battery Conference 2026 in Goa
  • Why Creator-Gear is a B2B Business now: agencies, schools, and production houses?
  • Prateek Group Brings The New Era of Luxury Real Estate

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Jogani Reinforcement’s Maheshkumar Jogani Receives Prestigious Award from India’s Road and Transportation Minister, Shree Nitin Gadkari Business
  • Karan Johar delivers another viral campaign for IITIIMShaadi.com Lifestyle
  • Magellanic Cloud Builds Strong Growth Momentum with Continuous Order Wins Worth Over ₹111.04 Crore Business
  • Nukleus Office Solutions Ltd Sponsors Chennai Smashers in Tennis Tournament Sports
  • Aakhar Gujarat Festival celebrates Gujarat’s literary and cultural diversity Lifestyle
  • Mr. Ranjit Kedia: Redefining Logistics with Heart, Vision, and Smiles Business
  • Medec Dragon Pvt Ltd Awarded “ASSOCHAM’S Most Promising Company in Corporate Governance”   Business
  • TiE Women Global Pitch Competition 2022 organised by TiE Surat Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme